Company news

Pulmatrix, Inc. news in 2020

Pulmatrix, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Pulmatrix Reports Third Quarter 2020 Financial Results and Business Updates

November 11, 2020

Pulmatrix Announces Commercial Launch of FEND, an OTC Nasal Hygiene Product Proven to Reduce Airborne Respiratory Droplets, with Partner Sensory Cloud

October 20, 2020

Pulmatrix Announces Publication Demonstrating Reduction of Bioaerosols with FEND, an OTC Nasal Hygiene Product Designed to Cleanse Airways of Airborne Particles

September 29, 2020

Pulmatrix Strengthens Board of Directors with Appointment of Todd Bazemore

September 28, 2020

Pulmatrix Reports Progress on Product Pipeline

September 21, 2020

Pulmatrix Reports Q2 2020 Results and Business Updates

August 6, 2020

Pulmatrix Announces Progress by Sensory Cloud Toward Commercial Launch of FEND in Fall 2020, an OTC Nasal Hygiene Product Designed to Suppress Exhaled Airborne Particles

July 7, 2020

Pulmatrix Announces Changes to Board of Directors

June 25, 2020

Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually

May 26, 2020

Pulmatrix Reports Q1 2020 Results

May 13, 2020

Pulmatrix Announces $8.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

April 15, 2020

Pulmatrix and Sensory Cloud Announce Partnership to Develop and Commercialize a Potential Nasal Prophylactic and Anticontagion Product for COVID-19

April 15, 2020

Pulmatrix Reports 2019 Financial Results and Provides Business Update

March 25, 2020

Pulmatrix Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA

January 29, 2020

Pulmatrix Regains Compliance with Nasdaq Minimum Bid Price Requirement

January 15, 2020

Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson

January 1, 2020

Decks in 2020